Ajooni Biotech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2025
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech Limited held its 15th AGM on September 29, 2025 at 11:00 a.m. via video conferencing, chaired by Managing Director Mr. Jasjot Singh. A total of 14 resolutions were transacted, including adoption of the audited financial statements for FY ended March 31, 2025 and the re-appointment of Mr. Partek Singh as director retiring by rotation. The company also sought shareholder approval for related party transactions with five entities — Healthy Biosciences, Punjab Biotechnology Park, Gilbert Kasauli, Revive Aesthetics and Khanna Solvex. Other key items included appointment of M/s. SDK & Associates as secretarial auditors for five years (FY 2025-26 to FY 2029-30), re-appointment of Mr. Gursimran Singh as Whole Time Director and Mr. Jasjot Singh as Managing Director with increased remuneration, and enabling approvals for loans, guarantees and investments under Sections 185 and 186 of the Companies Act.
The filing is procedural and confirms that all agenda items, including related party transactions and enhanced director remuneration, were put to vote. Actual outcomes (whether resolutions were passed and by what margin) are pending and will depend on the scrutinizer's report to be shared separately, which could materially affect shareholder perception — especially given multiple related party transaction approvals and an increase in Managing Director remuneration.